News
Vintage Energy (ASX: VEN) has made a strong start in its plans to ramp up production at the company’s Odin and Vali fields, ...
The escalating conflict between Israel and Iran has the Middle East and global markets on edge, with the price of a number of ...
The board of Santos (ASX: STO) has indicated its willingness to back a $30 billion takeover bid by global oil and gas giant ...
Amplia Therapeutics (ASX: ATX) has recorded the first pathological complete response (pCR) from a patient participating in ...
TIS (ASX: AR9) has licensed its NC Protect data-centric security software to an initial 1,000 users within the US Department of Defense (DoD). A prime ...
Vintage Energy (ASX: VEN) has further solidified its cash position with the sale of its 25% interest in non-core onshore ...
Unico Silver (ASX: USL) has announced the highest silver intercept to date following a Phase 3 exploration campaign at its ...
When it comes to active ETFs, Australia has been very slow to adopt much of the offshore innovation. Fortunately, we’re ...
Barton Gold (ASX: BGD) (OTCQB: BGDFF) has completed an expanded drilling campaign at the Tolmer high-grade silver discovery ...
The Australian share market was set for a rise on Friday until explosions in nuclear facilities near Iran’s capital Tehran ...
Get the latest market news, interviews and stock alerts. Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies. Small Caps and affiliated companies accept ...
Clinical-stage drug developer Syntara (ASX: SNT) has hit more milestones with its SNT-5505 blood cancer treatment candidate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results